A carregar...

A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD

BACKGROUND AND OBJECTIVES: Calcitriol is used to treat secondary hyperparathyroidism in patients with CKD. Paricalcitol is less calcemic and phosphatemic in preclinical studies and in some trials in dialysis patients, but head-to-head comparisons in nondialysis patients are lacking. A large meta-ana...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Coyne, Daniel W., Goldberg, Seth, Faber, Mark, Ghossein, Cybele, Sprague, Stuart M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4152818/
https://ncbi.nlm.nih.gov/pubmed/24970869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10661013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!